Skip to main content
Laxmi Dental Limited logo

Laxmi Dental Limited — Investor Relations & Filings

Ticker · LAXMIDENTL ISIN · INE0WO601020 LEI · 254900M8P2C921MMM832 BSE.NS Manufacturing
Open in API
Filings indexed 154 across all filing types
Latest filing 2026-05-18 Regulatory Filings
Country IN India
Listing BSE.NS LAXMIDENTL

About Laxmi Dental Limited

https://www.laxmidentallimited.com

Laxmi Dental Limited is a prominent dental laboratory and manufacturer specializing in high-quality dental prosthetics and digital dentistry solutions. The company provides a comprehensive range of products, including crowns, bridges, dentures, and dental implants. It is recognized for its advanced manufacturing capabilities, utilizing CAD/CAM technology and 3D printing to ensure precision and aesthetic excellence. A significant part of its portfolio includes clear aligner systems under the brand Illusion Aligners. The company serves a global clientele of dental professionals and clinics, focusing on innovation, quality control, and timely delivery. By integrating digital workflows with traditional craftsmanship, it offers customized restorative and orthodontic solutions designed to improve patient outcomes and clinical efficiency.

Recent filings

Filing Released Lang Actions
Pursuant to the Regulation 30(6), read with Schedule III Part A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, this is to ....
Regulatory Filings Classification · 78% confidence The document is a formal disclosure to stock exchanges under SEBI LODR, providing prior intimation of the schedule for the Q4FY26 earnings conference call. It does not contain any financial results, presentation slides, detailed investor presentation or the call transcript itself. It is an obligatory regulatory announcement, fitting best into the catch-all “Regulatory Filings” category (RNS).
2026-05-18 English
Laxmi Dental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve the Audited Financial Results ....
Regulatory Filings Classification · 88% confidence The document is a formal notice under Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing stock exchanges of a scheduled Board meeting to consider and approve audited financial results. It does not contain any financial results or data itself, nor is it a management discussion or report. It is an announcement of an upcoming regulatory event, fitting the fallback category of a regulatory filing rather than an actual report. Therefore, it should be classified as a Regulatory Filing (RNS).
2026-05-18 English
Monitoring Agency Report
Regulatory Filings
2026-05-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the schedule of analyst and institutional investor meetings (Non-Deal Roadshow). It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), which pertains to disclosure of material events and information. The content is about informing the exchanges and public about upcoming investor meetings, explicitly stating no unpublished price sensitive information will be discussed. There are no financial statements, detailed financial data, or report attachments. The document is an announcement of an event related to investor relations rather than a financial report or detailed presentation. This fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2026-04-17 English
General Updates
Share Issue/Capital Change Classification · 88% confidence The document is a formal intimation under SEBI LODR Regulation 30, informing exchanges of the in-principle approval for listing 500,000 new equity shares to be issued under the company’s 2024 ESOP. This clearly pertains to a proposed share issuance/capital change rather than an earnings release or management commentary. Therefore it fits the “Share Issue/Capital Change” category (SHA).
2026-04-10 English
General Updates
Capital/Financing Update Classification · 95% confidence The document is an official communication from Laxmi Dental Limited to stock exchanges (BSE and NSE) regarding the in-principle approval for listing equity shares under the company's Employee Stock Option Scheme 2024. It includes the approval letter from NSE granting in-principle approval subject to conditions. The content focuses on regulatory approval for listing new shares, not on financial results, management changes, or detailed financial reports. The document is about a capital market regulatory update related to share issuance and listing approval. Therefore, it fits best under Capital/Financing Update (CAP). The document length is over 6000 characters and contains substantive content, not just a brief announcement or a certification, so it is not RPA or RNS. Hence, the classification is CAP with high confidence.
2026-04-09 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.